Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 studyShubham Pant, Christophe Le Tourneau, Toshihiko Doi et al.|The Lancet Oncology|2023Cited by 195
PD-L1 gene amplification and focality: relationship with protein expressionDenis L. Jardim, Razelle Kurzrock|Journal for ImmunoTherapy of Cancer|2023Cited by 10